CVX vs PFE: Which Is the Better Buy?

Side-by-side comparison of Chevron Corporation and Pfizer Inc. β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-24.
Chevron Corporation Β· Energy
$205.52
+35.9% upside to fair value
Med Conviction Grade B High Quality
VS
Pfizer Inc. Β· Healthcare
$27.64
+12.0% upside to fair value
Med Conviction Grade B
QuantHub Verdict
CVX has more upside to fair value (+35.9%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric CVX PFE
Current Price $205.52 $27.64
Fair Value Estimate $279.29 $30.94
Upside to Fair Value +35.9% +12.0%
Market Cap $409.3B $157.5B
Forward P/E β€” β€”
EV / EBITDA 7.8x 17.4x
Price / Sales 2.0x 2.5x
Price / FCF 15.0x 14.3x
Revenue Growth YoY +51.4% +2.6%
Gross Margin 31.0% 71.3%
Operating Margin 15.8% 25.1%
Return on Equity 11.0% 4.9%
Dividend Yield 3.43% 6.22%
FCF Yield 6.67% 6.97%
Analyst Consensus Buy Hold
Investment Thesis
CVX β€” Chevron Corporation
Chevron is a global integrated oil and gas major organized into Upstream and Downstream segments, spanning crude oil and natural gas exploration, LNG processing and transport, refining, petrochemicals, and lubricants, with 43,039 full-time employees and a market capitalization of $409.31 billion at a current price of $205.52. The business quality is high: it generates $13.71 of free cash flow per…
PFE β€” Pfizer Inc.
Pfizer is a global biopharmaceutical leader with a portfolio spanning cardiovascular, oncology, vaccines, immunology, and rare disease, anchored by Eliquis, the Prevnar family, Vyndaqel, Ibrance, Xtandi, Comirnaty, and Paxlovid, and supported by roughly 75,000 employees and a contract manufacturing division. Business quality is medium rather than high: TTM gross margin of 71.3% and TTM operating …
Accumulation Zones
Metric CVX PFE
Zone Low $209.47 $23.21
Zone High $237.40 $26.30
In Buy Zone? Yes No
← CVX Research    PFE Research β†’    All Research